You searched for "Neuro-Ophthalmology"

2618 results found

BT for cyclic esotropia

This paper describes two patients with childhood cyclic esotropia treated with botulinum toxin (BT) and followed for eight and nine years. Onset was at two and four years of age. BT was injected under electromyography (EMG) guidance bilaterally to medial...

Use of polypropylene suture with glaucoma drainage tubes

The authors overview surgical techniques for initial non-valved glaucoma drainage device tube placement and a glaucoma drainage device tube extension using polypropylene suture as a guide wire and stabiliser in paediatric patients. The detailed technique for tube placement and tube...

Incidence and clinical characteristics of paediatric keratitis

This is a retrospective, population-based study of a 10-year period from Mayo Clinic, USA between January 2000 and December 2009 of patients <19 years diagnosed with keratitis. Two-hundred and eight-five children were identified. An incidence of 78 per 100,000 and...

Changing surgery trends from 2009–2020

This paper reports a review of the number and type of surgeries over one decade in a Portuguese hospital. This was a retrospective review of 2050 surgeries. About 70% were strabismus surgery and the remainder included anterior segment and retinopathy...

In conversation with Denize Atan (UK-EGG)

We spoke to Denize Atan, co-president of the UK Eye Genetics Group, about their upcoming meeting in June, and her recent session entitled ‘Neuro-ophthalmology Nightmares’.

In conversation with Robert Dempsey (2017)

The new Head of Global Ophthalmics at Shire met us at the 2017 Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), to tell us why Shire feels the time is right to launch into ophthalmology. Click the...

Moorfields: Ophthalmic emergency study day Apr 26

Moorfields Education: Ophthalmic emergency study day

RCOphth: MIGS Club

The Royal College of Ophthalmologists Minimally Invasive Glaucoma Surgery (MIGS) Club

AI can identify treatment gaps for patients with macular disease, study shows

Using artificial intelligence (AI) in eye clinics could reduce both undertreatment and overtreatment of neovascular or ‘wet’ age-related macular degeneration (AMD). AMD is the leading cause of irreversible vision loss in older people and accounts for around 1 in 10...

All eyes on the future symposium hailed a great success

Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...